GSP Crop Science IPO: Subscribe or Skip? GMP, Subscription, Key Details Explained
GSP Crop Science IPO sees muted retail demand and flat GMP, signalling limited listing gains despite moderate institutional interest.
The initial public offering of GSP Crop Science Ltd has opened for subscription and will close on March 18, 2026, with investors closely tracking demand trends and grey market signals.
The Rs 400 crore IPO is a book-built issue comprising a fresh issue of 75 lakh shares worth Rs 240 crore and an offer for sale of 50 lakh shares worth Rs 160 crore.
The price band has been fixed at Rs 304 to Rs 320 per share, with a lot size of 46 shares. At the upper band, retail investors need a minimum investment of Rs 14,720.
The issue opened on March 16 and is scheduled to close on March 18. The allotment is expected to be finalised on March 20, while listing on the Bombay Stock Exchange and the National Stock Exchange is likely on March 24.
Equirus Capital Pvt Ltd is the book running lead manager, while MUFG Intime India Pvt Ltd is the registrar to the issue.
Subscription status
As of March 17, 2026, around 12:44 pm, the IPO has been subscribed 0.67 times overall.
The retail category remains under-subscribed at 0.16 times. The qualified institutional buyers segment, excluding anchor investors, has been subscribed 1.28 times, while the non-institutional investor category stands at 1.04 times.
The data indicates relatively stronger participation from institutional investors compared to retail investors.
GMP trend
The grey market premium for the IPO is currently Rs 0. Based on the upper price band of Rs 320, the estimated listing price remains around Rs 320, indicating no expected listing gains at present.
A flat GMP generally reflects weak demand in the unofficial market.
Company profile
GSP Crop Science Ltd, incorporated in 1985, operates in the agrochemical sector. The company manufactures insecticides, herbicides, fungicides and plant growth regulators.
Its business spans formulations and technicals, offering crop protection solutions aimed at improving farm productivity. The company focuses on developing, manufacturing and distributing agrochemical products.
Should you subscribe?
The IPO presents a mixed outlook. Institutional demand has been moderate, while retail participation remains weak.
The flat GMP suggests limited scope for short-term listing gains. Investors may track final day subscription data and assess long-term fundamentals before taking a call.
The decision to subscribe may depend on individual risk appetite and investment horizon, as current indicators do not point to immediate gains.